Bioresponsive Functional Phenylboronic Acid-Based Delivery System as an Emerging Platform for Diabetic Therapy
Qiong Ma,1 Xi Zhao,1 Anhua Shi,1 Junzi Wu1,2 1The Key Laboratory of Microcosmic Syndrome Differentiation, Education Department of Yunnan, Yunnan University of Chinese Medicine, Kunming, Yunnan 650500, People’s Republic of China; 2Department of Medical Biology, College of Basic Medicine, Yu...
Guardado en:
Autores principales: | Ma Q, Zhao X, Shi A, Wu J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9d7bc60c8daa4367a2c3d8288500ee43 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Inhibition of proliferation and migration of tumor cells through phenylboronic acid-functionalized polyamidoamine-mediated delivery of a therapeutic DNAzyme Dz13
por: Yang J, et al.
Publicado: (2019) -
Sulfonate-modified phenylboronic acid-rich nanoparticles as a novel mucoadhesive drug delivery system for vaginal administration of protein therapeutics: improved stability, mucin-dependent release and effective intravaginal placement
por: Li CY, et al.
Publicado: (2016) -
Glucose-Sensitive Nanoparticles Based On Poly(3-Acrylamidophenylboronic Acid-Block-N-Vinylcaprolactam) For Insulin Delivery
por: Wu J, et al.
Publicado: (2019) -
Glucose-responsive mesoporous silica nanoparticles to generation of hydrogen peroxide for synergistic cancer starvation and chemistry therapy
por: Du X, et al.
Publicado: (2019) -
Glucose- and temperature-sensitive nanoparticles for insulin delivery
por: Wu JZ, et al.
Publicado: (2017)